Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
How To Capture Growth In The Expanding Metabolic Drug Market
Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.
-
What's Next In Pharmaceutical R&D?
Emerging R&D trends focus on novel pulmonary and nasal delivery methods. Solubility remains a key challenge, addressed through techniques like microfluidics for nanosuspensions.
-
How One Biotech Company Is Accelerating The Drug Discovery Workflow
See how biotech innovation is accelerating drug discovery through AI, miniaturized workflows, and collaborative technologies to reshape how therapies are developed and delivered.
-
Advanced Therapies Going Mainstream: Are We There Yet?
Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.
-
Patient-Centric Formulations In Pediatric Adherence
Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Efficient Stem Cell Expansion In Bioreactors For Immunotherapy
A scalable bioreactor process enables efficient expansion of cord blood-derived HSCs and NK cell differentiation, delivering high purity and strong cytotoxicity, advancing immune cell therapies.
-
Cell Culture Media Mixing In A Benchtop Single-Use Mixer
Explore how efficient powder-liquid mixing and sterile filtration preserve media integrity and support reproducibility in biopharmaceutical workflows, with promising scalability for larger-volume applications.
-
Assessing Particle Generation In A Single-Use Mixing System
Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.
-
Your Guide To Precise And Robust Separation Methods
Discover a detailed guide to characterizing GLP-1 receptor agonists that covers advanced LC-MS and SEC-MALS workflows for impurity profiling, stability testing, and aggregate analysis.
-
Simplify Cell Line Development
A streamlined workflow combining microfluidic dispensing and multimodal imaging enables efficient single-cell isolation, viability assessment, and outgrowth analysis to support cell line development.
FORMULATION DEVELOPMENT SOLUTIONS
- An Innovative Service Model With Flexibility And Rapid Response
- Comprehensive Support For Regulated Laboratories With FlexCHOICE Service Coverage
- A Technology-Driven CDMO Delivering Integrated End-To-End Services
- High-Purity Analytical Solvents: Consistent Quality For Applicants
- A Viral Safety Solution Designed To Provide Retention Assurance And Productivity
- Tailored Process Development Services Designed For Success
- Molecule To Cure. Fast.
- Dynamic And Ergonomic Oligosynthesis Column
- Cell Therapy Product Characterization Services
- High-Quality Filter Housings For Sanitary Applications
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- $6B Commitment: Eli Lilly Expands U.S. Manufacturing With New Huntsville Facility
- Bora Pharmaceuticals And Corealis Pharma Forge Strategic Alliance To Deliver Seamless, End-To-End Oral Solid Dose Development
- Marchesini Group And AST Unite To Expand Global Sterile Fill-Finish Capabilities
- Late-Model Lab & Bioprocess Equipment From Premier Biopharma Facility To Be Offered For Sale December 4–9, 2025
- Bora Pharmaceuticals Marks Five Years In Mississauga, Canada, Strengthening Its Commitment To Onshore And Global CDMO Excellence
- Techceuticals Announces 2026 Solid Dosage Manufacturing Process Training Schedule
- Quotient Sciences And Intrepid Labs Form Strategic Partnership To Accelerate AI-Guided Formulation Development
- Large-Capacity Double Planetary Mixer Ideal For Highly Viscous Materials
- CSL To Build Out U.S. Plasma Capabilities Through $1.5B Investment
- Equipment Auction Announced For Sutro Biopharma Assets